- Minimally invasive vertebral compression fracture treatments, which include procedures such as vertebroplasty and kyphoplasty, are becoming essential solutions in modern spinal care due to their ability to relieve pain, restore vertebral height, and improve mobility with reduced recovery time compared to open surgery
- The increasing demand for these treatments is primarily fuelled by the global rise in osteoporosis-related fractures, growing awareness of minimally invasive techniques among patients and physicians, and the expanding elderly population prone to spinal degeneration and trauma-related compression fractures
- North America dominates the minimally invasive vertebral compression fracture treatments market with the largest revenue share of 38.7% in 2024, supported by advanced healthcare infrastructure, higher healthcare spending, and the rapid adoption of innovative spinal surgery technologies
- Asia-Pacific is projected to be the fastest growing region in the minimally invasive vertebral compression fracture treatments market, with a CAGR of 10.8% from 2025 to 2032. This growth is driven by increasing geriatric populations, rising incidence of osteoporosis, and greater access to quality healthcare services in emerging markets such as China, India, and South Korea
- The balloon kyphoplasty segment dominates the minimally invasive vertebral compression fracture treatments market with a market share of 47.6% in 2024, owing to its ability to not only stabilize fractures but also restore vertebral body height and reduce kyphotic deformities. Its clinical benefits and growing preference in both hospital and outpatient settings contribute to its leadership in the market
